Percentage inhibition of hemolysis by 6-shogaol-rich ginger extract (0–200 µg/mL) and ascorbic acid (AA; 100 µg/mL) in red blood cells obtained from thalassemia patients (A) and he... by Hataichanok Chuljerm (19144293)

Subjects:

HPLC chromatogram of standard 6-gingerol (0.2 mg/mL) (a), 6-shogaol (0.2 mg/mL) (b), ginger extract obtained by conventional maceration (c), and ginger extract obtained by pulsed e... by Hataichanok Chuljerm (19144293)

Subjects:

Main baseline characteristics of patients included in the study. by Jie Liu (15128)

Subjects:

(A) Monthly drug costs of patients in the ESAs group and Roxadustat group. by Jie Liu (15128)

Subjects:

Study data. by Jie Liu (15128)

Subjects:

Total phenolic content (TPC) and total flavonoid content (TFC) in ginger extract obtained from conventional maceration and pulsed electric field extraction. by Hataichanok Chuljerm (19144293)

Subjects:

Graphical abstract_6-Shogaol ginger. by Hataichanok Chuljerm (19144293)

Subjects:

Morisky score for ESAs group and Roxadustat group. by Jie Liu (15128)

Subjects:

The concentration of 6-gingerol (A) and 6-shogaol (B) in the ginger extract obtained from conventional maceration and pulsed electric field (PEF) extraction. by Hataichanok Chuljerm (19144293)

Subjects:

Patient flow diagram. by Jie Liu (15128)

Subjects:

Susceptibility of thalassemic and healthy RBCs to hemolysis (A) and the anti-hemolytic activity of 6-shogaol-rich ginger extract (0–200 µg/mL) compared to ascorbic acid (AA; 100 µg... by Hataichanok Chuljerm (19144293)

Subjects:

Summary of clinical outcomes after 9 months. by Jie Liu (15128)

Subjects:

The percentage of DPPH^• (A) and ABTS^•+ (B) inhibition of 6-shogaol-rich ginger extract and Trolox. by Hataichanok Chuljerm (19144293)

Subjects:

Approval by the research ethics committee. by Jie Liu (15128)

Subjects:

(A) Changes of left ventricular ejection fraction over time in Roxadustat and ESAs groups. by Jie Liu (15128)

Subjects:

Predictive Significance of Glycosyltransferase-Related lncRNAs in Endometrial Cancer: A Comprehensive Analysis and Experimental Validation by Xiaoyu Shen (4715430)

Subjects:

Impact of red blood cell-platelet ratio trajectories in the first four days before ICU admission on prognosis and clinical outcomes in the validation set. by Jie Zhao (49409)

Subjects:

Impact of red blood cell-platelet ratio trajectories on prognosis and clinical outcomes in the first four days before ICU admission in the training set. by Jie Zhao (49409)

Subjects:

MXene/Bi₂O₃ Nanocomposites as Supercapacitors for Portable Electronic Devices by Nanasaheb M. Shinde (8560572)

Subjects:

Cis-acting elements in the promoter of PtWRKYs. by Yuzhao Ma (12840632)

“…Under cadmium toxicity, <i><i>the plant</i></i> height of <i><i>PsnWRKY95</i></i>-overexpressing plants increased by 16%−26% compared with the wild type (WT), the root length increased by 12%−27% compared with WT, the peroxidase (POD) activity was 28%−51% higher than that of WT, the chlorophyll content increased by 15%−29% compared with WT, the malondialdehyde (MDA) content decreased by 13%−32% compared with WT, and the electrical conductivity decreased by 9%−20% compared with WT, with the expression levels of <i>POD</i> and <i>HMA1</i> in the overexpressing plants also being higher than those in WT. …”